Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

967 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 967 results

Testing effectiveness (Phase 2)Looking for participantsNCT06791148
What this trial is testing

Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer

Who this might be right for
Gastric Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 45
Large-scale testing (Phase 3)Study completedNCT00917384
What this trial is testing

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Who this might be right for
Gastric CancerAdenocarcinoma
Eli Lilly and Company 355
Testing effectiveness (Phase 2)Ended earlyNCT00061958
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusStage III Esophageal CancerStage IV Esophageal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)UnknownNCT05241899
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 56
Large-scale testing (Phase 3)UnknownNCT02381847
What this trial is testing

Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients

Who this might be right for
Malignant Neoplasm of Stomach
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Testing effectiveness (Phase 2)Looking for participantsNCT06161818
What this trial is testing

Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

Who this might be right for
Esophageal CancerAdenocarcinoma of the Esophagus
Erasmus Medical Center 216
Testing effectiveness (Phase 2)Looking for participantsNCT05753306
What this trial is testing

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
Mayo Clinic 40
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Looking for participantsNCT06038578
What this trial is testing

TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastric CancerGastroesophageal Junction Adenocarcinoma
Toray Industries, Inc 146
Testing effectiveness (Phase 2)UnknownNCT05750290
What this trial is testing

CKD-702 Plus Irinotecan in Gastric Cancer

Who this might be right for
Gastric Cancer
National Cancer Center, Korea 40
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Not applicableNot Yet RecruitingNCT07775859
What this trial is testing

NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancerGastric CancerGastroesophageal Junction Cancer+2 more
Peking University Cancer Hospital & Institute 200
Testing effectiveness (Phase 2)Looking for participantsNCT07818018
What this trial is testing

2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Esophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07257380
What this trial is testing

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital 90
Not applicableWithdrawnNCT01627080
What this trial is testing

Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00165191
What this trial is testing

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Who this might be right for
Adenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus
Dana-Farber Cancer Institute 32
Not applicableActive Not RecruitingNCT06243757
What this trial is testing

Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Who this might be right for
Gastric CancerGastroEsophageal CancerGastroesophageal Junction Adenocarcinoma
Memorial Sloan Kettering Cancer Center 4
Next Page